Skip to main content

Table 2 Hepatitis B antibody titers based on the rout of vaccination

From: Levamizole enhances immune responsiveness to intra-dermal and intra-muscular hepatitis B vaccination in chronic hemodialysis patients

HB vaccine groups

positive seroconversion rate after 1 month (antibody titer/IU)

positive seroconversion rate after 6 months (antibody titer/IU)

Group A (intra-muscular route by 40 microgram vaccine alone)

60% (28.9 ± 7) *P = 0.04

20% (16.7 ± 4)

Group B (intra-dermal route by 20 microgram vaccine alone)

70% (121.1 ± 82.3) #p = 0.005

60% (58 ± 7)

Group C (intra-muscular route by 20 microgram vaccine plus Levamisole)

90% (543.1 ± 494.4) §p = 0.008

80% (304 ± 7)

Group D (intra-dermal route by 20 microgram vaccine plus Levamisole)

90% (297.2 ± 90) €p = 0.6

80% (209 ± 46)

  1. Seroconversion rate percent (when Ab titer was more than10 IU/L) and HB antibody titers (IU/L) one month and six months after different routs of vaccination. *Denotes comparison of antibody titer between groups A and B.
  2. # Denotes comparison of antibody titer between groups B and D.
  3. §Denotes comparison of antibody titer between groups A and C.
  4. € Denotes comparison of antibody titer between groups C and D.